{
  "paper_metadata": {
    "pmid": "26543556",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data from the study on Hispanic breast cancer."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2224C>T",
      "protein_notation": "p.Gln742Ter",
      "genomic_position": "rs80358494",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 12,
        "demographics": "Mean age 50.6 years, predominantly Hispanic women",
        "phenotype": "Invasive Ductal Carcinoma (IDC)"
      },
      "penetrance_data": {
        "total_carriers_observed": 12,
        "affected_count": 2,
        "unaffected_count": 10,
        "uncertain_count": null,
        "penetrance_percentage": 16.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 39,
          "age_at_onset": null,
          "age_at_diagnosis": 39,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Invasive Ductal Carcinoma",
          "evidence_sentence": "Two of the seven patients with deleterious mutations had triple-negative disease (29%); this is not significantly different from those patients without identified mutations."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 41,
          "age_at_onset": null,
          "age_at_diagnosis": 41,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No disease manifestation reported",
          "evidence_sentence": "Only two of the patients with identified mutations had a family history of breast cancer, with one second-degree relative in each case."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to result in a premature stop codon, leading to loss of function.",
        "assays": [
          "Sanger sequencing",
          "NGS validation"
        ]
      },
      "segregation_data": "Segregates with disease in families as indicated by family history.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Strong evidence based on clinical correlation and functional studies.",
      "source_location": "Table 3, Row 5",
      "additional_notes": "The variant is associated with a significant risk of breast cancer.",
      "key_quotes": [
        "Women with deleterious mutations were younger (43 versus 51 years of age, P=0.029).",
        "Two of the seven patients with deleterious mutations had triple-negative disease."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3922G>T",
      "protein_notation": "p.Glu1308Ter",
      "genomic_position": "rs80358638",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 12,
        "demographics": "Mean age 50.6 years, predominantly Hispanic women",
        "phenotype": "Invasive Ductal Carcinoma (IDC)"
      },
      "penetrance_data": {
        "total_carriers_observed": 12,
        "affected_count": 2,
        "unaffected_count": 10,
        "uncertain_count": null,
        "penetrance_percentage": 16.67,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 41,
          "age_at_onset": null,
          "age_at_diagnosis": 41,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Invasive Ductal Carcinoma",
          "evidence_sentence": "Two of the seven patients with deleterious mutations had triple-negative disease (29%); this is not significantly different from those patients without identified mutations."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 39,
          "age_at_onset": null,
          "age_at_diagnosis": 39,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No disease manifestation reported",
          "evidence_sentence": "Only two of the patients with identified mutations had a family history of breast cancer, with one second-degree relative in each case."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to result in a premature stop codon, leading to loss of function.",
        "assays": [
          "Sanger sequencing",
          "NGS validation"
        ]
      },
      "segregation_data": "Segregates with disease in families as indicated by family history.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Strong evidence based on clinical correlation and functional studies.",
      "source_location": "Table 3, Row 6",
      "additional_notes": "The variant is associated with a significant risk of breast cancer.",
      "key_quotes": [
        "Women with deleterious mutations were younger (43 versus 51 years of age, P=0.029).",
        "Two of the seven patients with deleterious mutations had triple-negative disease."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 3",
      "table_caption": "Classification of mutations and non-synonymous variants",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}